Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Limited has announced the issuance of 29,465 service rights under an employee incentive scheme, which will not be quoted on the ASX. These unquoted equity securities were issued on May 27, 2024, contributing to the company’s strategy of rewarding and retaining its employees.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
